Discover. Transform. Cure. Impact.
Future of drug discovery.
BioXscience based in Rotterdam, Netherlands, is a small biomedical company that is active in research, product development, and production of medicines for diseases caused by immune response disorders such as Rhinitis, Asthma, Psoriasis, Vitiligo, inflammatory bowel disease (Crohn’s disease, Ulcerative colitis).
BioXscience is leading the way in creating new medicines, especially for diseases related to problems with the immune system. With strong research and a clear focus on immune system issues, BioXscience aims to change how we treat many diseases and make a big difference in global health.
Specialization
Medicines for immune response disorders including Rhinitis, Asthma, Psoriasis, Vitiligo, inflammatory bowel disease, and Idiopathic hypoglycaemia.
Competitive Advantage
Speed to Market: no hurdles of drug development
Safety Profile: our products have demonstrated minimal side effects and absence of contra-indications
Reduced Risk: lower chances of technical product failures and overdosing
Competitive Advantage
Products & Services
Developed therapeutic solutions that target immune response disorders with a distinct metabolic working mechanism.
Recorded minimal side effects with no known contra-indications for the current product pipeline.
Ready-to-launch products that can immediately proceed to clinical testing
History
Although recently established, the company has conceptualized, developed, and verified its therapeutic concepts over a decade and a half.